Push Admin

Antibody tests key to ending COVID-19 lockdowns

Article (news)

Paul Ricard, Agence France-Presse

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="https://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/04/02/covid_1.jpg"/><figcaption>A scientist works in the lab of Linqi Zhang on research into novel coronavirus disease (COVID-19) antibodies for possible use in a drug at Tsinghua University&#x27;s Research Center for Public Health in Beijing, China, March 30, 2020. Thomas Peter, Reuters</figcaption></figure></div>PARIS - It&#x27;s the key that opens to door from total lockdown: serologic testing, which will show definitively who has contracted COVID-19 and is in theory safe to return to work.&quot;Everyone&#x27;s waiting for serologic testing, the whole world,&quot; said France&#x27;s Health Minister Olivier Veran. He said that the global research community was focusing on ways of perfecting the tests, which measure viral antibodies in a person&#x27;s blood that signal immunity.Veran said that mass production of the tests could start within weeks. &quot;It&#x27;s a huge factor, especially when we&#x27;re trying to reduce confinement,&quot; he said.The World Health Organization said that serologic tests were still being developed but were yet to be properly evaluated. <div>&#x27;GREAT INTEREST&#x27;</div>Current diagnostic tests, known as RT-PCR, are invasive and use genetic analysis to see if a person is actively infected.Serologic testing, which only requires a drop of blood to conduct, focuses instead on finding virus antibodies, the presence of which indicates that an individual has had COVID-19 and is now likely immune.&quot;Antibodies are one of the key immune response components. They start to be detectable around a week after initial infection,&quot; said Andrew Preston, a reader in Microbial Pathogenesis at the University of Bath.There are two types of antibodies associated with the COVID-19 immune response: IgM, which the body produces in the early stages of viral response, and IgG, which arrive later on during infection. The tests being developed can identify both antibodies, key hallmarks of a patient&#x27;s auto-immune response to the virus.&quot;Thus there is great interest in the use of an antibody test to indicate immunity against disease for use in the lifting of lockdown restrictions,&quot; said Preston.<div>SUPPLY PROBLEM</div>Antibody testing is so crucial because of the large proportion of people with COVID-19 infections who may not show symptoms but can still pass the virus on to others.Such tests already exist for other illnesses. And once they are perfected for the novel coronavirus the results can be analyzed in labs using existing hardware.Once widely available, they could be used to determine who gets to return to work and exit the lockdown currently being experienced by billions around the world.&quot;The main question is how to ensure everyone can return to work,&quot; Francois Blanchecotte, president of the French Union of Biologists, told AFP.In Italy, the president of the Venice region, Luca Zaia, has proposed that returning workers carry a document after testing to prove they aren&#x27;t contagious.Similar measures have been proposed in Germany.&quot;A GP told me yesterday that if I gave him a serologic test and it showed that he&#x27;s immune, he would offer his services to a neighboring hospital&#x27;s COVID-19 unit in an flash,&quot; said Philippe Herent, director of the Synlab Opale group of laboratories. He, however, cautioned that global demand for the tests is likely to significantly outstrip demand, and production remains limited.<div>CAVEATS</div>The tests aren&#x27;t the perfect solution, however. &quot;They have to be used carefully. Used too early, the convalescent patient may still be carrying and shedding the virus, they may still be a risk to others,&quot; said Michael Skinner, a reader in Virology at Imperial College London. It&#x27;s due to this risk that countries are likely to continue producing and using RT-PCR tests and combine them with the serological versions.&quot;You might see a mix of the two: one diagnosis to see if you&#x27;re still contagious and a serological test to know if you have antibodies,&quot; said Blanchecotte.Another potential pitfall is that it is not yet known for certain whether people who have recovered from COVID-19 are immune to reinfection.&quot;In a vast majority of infectious diseases, recovery from disease and evidence of a strong immune response would lead to a period of immunity from re-occurrence,&quot; said Preston.&quot;(But) the caveat is that we don&#x27;t know for sure that a positive antibody test does imply someone is immune (from COVID-19).&quot;Most countries in lockdown still lack testing capacity, so it is not at all clear when restrictions on movement could be lifted, even with a widely available antibody test.But serologic tests are the only way to know for sure what percentage of humanity has been infected with COVID-19, which will help inform a variety of current unknowns, not least mortality rates.

Serologic testing, which only requires a drop of blood to conduct, focuses on finding virus antibodies, the presence of which indicates that an individual has had COVID-19 and is now likely immune.

Serologic testing, which only requires a drop of blood to conduct, focuses on finding virus antibodies, the presence of which indicates that an individual has had COVID-19 and is now likely immune.

Antibody tests key to ending COVID-19 lockdowns

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

Spotlight

Antibody tests key to ending COVID-19 lockdowns

Paul Ricard,

Agence France-Presse

Published Apr 03, 2020 01:20 AM PHT

Read More:

antibody test

serologic test

testing

Paris

France

ealth

virus

coronavirus

2019 Novel Coronavirus

2019-nCoV

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.